Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo
- 13 August 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 399 (1), 79-83
- https://doi.org/10.1016/j.bbrc.2010.07.045
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 20 references indexed in Scilit:
- The Akt kinases: Isoform specificity in metabolism and cancerCell Cycle, 2009
- Androgen receptor and growth factor signaling cross-talk in prostate cancer cellsEndocrine-Related Cancer, 2008
- Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinomaBreast Cancer Research and Treatment, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate CancerCancer Research, 2004
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- AKT1/PKBα Kinase Is Frequently Elevated in Human Cancers and Its Constitutive Activation Is Required for Oncogenic Transformation in NIH3T3 CellsThe American Journal of Pathology, 2001
- Identification of a Human Akt3 (Protein Kinase B γ) Which Contains the Regulatory Serine Phosphorylation SiteBiochemical and Biophysical Research Communications, 1999
- Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulinOncogene, 1998